Journal article
T-Cell Expression of Angiotensin-Converting Enzyme 2 and Binding of Severe Acute Respiratory Coronavirus 2
The Journal of infectious diseases, Vol.225(5), pp.810-819
03/02/2022
DOI: 10.1093/infdis/jiab595
PMCID: PMC8754779
PMID: 34918095
Abstract
Abstract
The pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not completely understood. SARS-CoV-2 infection frequently causes significant immune function consequences including reduced T cell numbers and enhanced T cell exhaustion that contribute to disease severity. The extent to which T cell effects are directly mediated through infection or indirectly result from infection of respiratory-associated cells is unclear. We show that primary human T cells express sufficient levels of angiotensin converting enzyme 2 (ACE-2), the SARS-CoV-2 receptor, to mediate viral binding and entry into T cells. We further show that T cells exposed to SARS-CoV-2 particles demonstrate reduced proliferation and apoptosis compared to uninfected controls, indicating that direct interaction of SARS-CoV-2 with T cells may alter T cell growth, activation, and survival. Regulation of T cell activation and/or turnover by SARS-CoV-2 may contribute to impaired T cell function observed in patients with severe disease.
No specific interaction between SARS-CoV-2 and T-cells is described. SARS-CoV-2 receptor (ACE-2) mRNA and protein were expressed in T-cells, and expression increased following T-cell activation. ACE-2 also mediated SARS-CoV-2 and spike protein entry, resulting in altering T-cell proliferation and apoptosis.
Details
- Title: Subtitle
- T-Cell Expression of Angiotensin-Converting Enzyme 2 and Binding of Severe Acute Respiratory Coronavirus 2
- Creators
- Jennifer L Welch - University of IowaJinhua Xiang - University of IowaQing Chang - University of IowaJon C D Houtman - University of IowaJack T Stapleton - University of Iowa
- Resource Type
- Journal article
- Publication Details
- The Journal of infectious diseases, Vol.225(5), pp.810-819
- DOI
- 10.1093/infdis/jiab595
- PMID
- 34918095
- PMCID
- PMC8754779
- NLM abbreviation
- J Infect Dis
- ISSN
- 0022-1899
- eISSN
- 1537-6613
- Publisher
- Oxford University Press
- Grant note
- DOI: 10.13039/100000002, name: National Institutes of Health, award: 5T32AI343; DOI: 10.13039/100000054, name: National Cancer Institute, award: P30CA086862; DOI: 10.13039/100015515, name: Carver College of Medicine; DOI: 10.13039/100011343, name: Holden Comprehensive Cancer Center
- Language
- English
- Date published
- 03/02/2022
- Academic Unit
- Microbiology and Immunology; Infectious Diseases; Internal Medicine
- Record Identifier
- 9984297433202771
Metrics
15 Record Views